Meta-analysis of DRD3 gene and Schizophrenia: Ethnic heterogeneity and significant association in Caucasians

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 81, Issue 4, 1998, Pages 318-322

  Dubertret, Caroline ^a   Gorwood, Philip ^a,b   Ades, Jean ^a   Feingold, Josue ^b   Schwartz, Jean Charles ^b   Sokoloff, Pierre ^b  

^a HÔPITAL LOUIS MOURIER   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE 3 RECEPTOR;

AFRICA; ARTICLE; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEPTOR GENE; SCHIZOPHRENIA;

DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SCHIZOPHRENIA;

EID: 0032503922     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19980710)81:4<318::AID-AJMG8>3.0.CO;2-P     Document Type: Article

References (32)

1. Asherson P, Mant R, Holmans P, Williams J, Cardno A, Murphy K, Jones L, Collier D, McGuffin P, Owen MJ (1996): Linkage, association and mutational analysis of the dopamine D3 receptor gene and schizophrenia. Mol Psychiatry 1:125-132.
2. Cagle M, Peacock ML, Matthay JG, Sunnenberg C, Tandon R, Meltzer H, Fink JK (1993): Dopamine D3 receptor gene polymorphism in schizophrenia. Am J Hum Genet 53:783.
3. Carlsson A (1988): The current status of the dopamine hypothesis of schizophrenia. Neuropharmacology 1:179-185.
4. Carlsson A, Lindqvist M (1963): Effect of chlorpromazine or haloperidol or formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20:140-144.
5. Chen CH, Liu MY, Wei FC, Koong FJ, Hwu HG, Hsiao KJ (1997): Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene and schizophrenia. Am J Med Genet 74:40-43.
6. Coon H, Byerley W, Holik J, Hoff M, Myles-Worsley M, Lannfelt L, Sokoloff P, Schwartz JC (1993): Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees. Am J Hum Genet 52:327-334.
7. Coughlin SS, Benichou J, Weed DL (1994): Attributable risk estimation in case-control studies. Epidemiol Rev 16:51-64.
8. Crocq MA, Mant R, Asherson P, Williams J, Hode Y, Mayerova A, Collier A, Lannfelt L, Sokoloff P, Schwartz JC, Gill M, Macher JP, McGuffm P, Owen MJ (1992): Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 29:858-860.
9. Crocq MA, Buguet A, Bisser S, Burgert E, Stanghellini A, Uyanik G, Dumas M, Macher JP, Mayerova A (1996): Ball and MspI polymorphisms of dopamine D3 receptor gene in African blacks and Caucasians. Hum, Hered 46:58-50.
10. Diaz J, Ridray S, Mignon V, Griffon N, Schwartz JC, Sokoloff P (1997) Selective expression of dopamine D3 receptor in proliferative zones during embryonic development of the rat brain. J Neurosci 17:4282-4292.
11. Di Bella D, Catalano M, Strukel A, Nobile M, Novelli E, Smeraldi E (1994): Distribution of the MscI polymorphism of the dopamine D3 receptor in an Italian psychotic population. Psychiatr Genet 4:39-42.
12. Durany N, Thome J, Palomo A, Foley P, Riederer P, Cruz-Sanchez FF (1996): Homozygosity at the dopamine D3 receptor gene in schizophrenic patients. Neurosci Lett 220:151-154.
13. Ebstein RP, Macciardi F, Heresco-Levi U, Serretti A, Blaine D, Verga M, Nebamov L, Gur E, Belmarker RH, Avnon M, Leler B (1997): Evidence for an association between the dopamine D3 receptor gene DRD3 and schizophrenia. Hum Hered 49:6-16.
14. Gaitonde EJ, Morris A, Sivagnanasundaram S, McKenna PJ, Hunt DM, Mollon JD (1996): Assessment of association of D3 dopamine receptor MscI polymorphism with schizophrenia: Analysis of symptom ratings, family history, age at onset, and movement disorders. Am J Med Genet 67:455-458.
15. Gottesman I, Shields J (1982): "Schizophrenia, the Epigenetic Puzzle." Cambridge: Cambridge University Press, pp 209-233.
16. Greenberg DA (1993): Linkage analysis of necessary disease loci versus susceptibility loci. Am J Hum Genet 52:135-143.
17. Greenberg DA, Hodge SE (1989): Linkage analysis under random and "genetic" reduced penetrance. Genet Epidemiol 6:259-264.
18. Griffon N, Crocq MA, Pilon C, Martres MP, Mayerova A, Uyanik G, Burgert E, Duval F, Marcher JP, Javoy-Agid F, Tamminga CA Schwartz JC, Sokoloff P (1996): Dopamine D3 receptor gene: Organization, transcript variants, and polymorphism associated with schizophrenia. Am J Med Genet 67:63-70.
19. Gurevich EV, Bordelon Y, Shapiro RM, Arnold SE, Gur R, Joyce JN (1997) Mesolimbic dopamine D3 receptors and use of antipsychotics in pa-tients with schizophrenia, a postmortem study. Arch Gen Psychiatry 54:225-232.
20. Hodge SE (1993): Linkage analysis versus association analysis: Distinguishing between two models that explain disease-marker associations. Am J Hum Genet 53:367-384.
21. Inada T, Sugita T, Dobashi I, Inagaki A, Kitao Y, Matsuda G, Kato S, Takano T, Yagi G, Asai M (1995): Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first-break schizophrenic patients. Psychiatr Genet 5:113-116.
22. Janowsky DS, Davis JM (1976): Methylphenidate, dextroamphetamine, and levamphetmine: Effects on schizophrenic symptoms. Arch Gen Psychiatry 33:304-308.
23. Jönsson E, Lannfelt L, Sokoloff P, Schwartz JC, Sedvall G (1993): Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene. Acta Psychiatr Scand 87:345-349.
24. Kennedy JL, Billett EA, Macciardi FM, Verga M, Parsons TJ, Meltzer HY, Lieberman J, Buchanan JA (1995): Association study of dopamine D3 receptor gene and schizophrenia. Am J Med Genet 60:558-562.
25. Lannfelt L, Sokoloff P, Martres MP, Pilon C, Giros B, Jönsson E, Sedvall G, Schwartz JC (1993): Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr Genet 2:249-256.
26. Laurent C, Savoye C, Samolyk D, Meloni R, Mallet J (1994): Homozygosity at the dopamine D3 receptor locus is not associated with schizophrenia. J Med Genet 31:260-264.
27. Lundstrom K, Turpin MP (1996): Proposed schizophrenia-related gene polymorphism: Expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki forest virus system. Biochem Biophys Res Commun 225:1068-1072.
28. Maggio R, Vogel Z, Wess J (1993): Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. Proc Natl Acad Sci USA 90: 3103-3107.
29. Mant R, Williams J, Asherson P, Parfitt E, McGuffin P, Owen MJ (1994): Relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia. Am J Med Genet 54:21-26.
30. Maziade M, Martinez M, Rodrigue C, Gauthier B, Simard C, Roy MA, Rouillard E, Mérette C (1997): Childhood/early adolescence-onset and adult-onset schizophrenia - Heterogeneity at the dopamine D3 receptor gene. Br J Psychiatry 170:27-30.
31. McGuffin P (1988): Genetics of schizophrenia. In Bebbington P, McGuffin P (eds): "Schizophrenia, The Major Issues." London: Heinemann Medical, pp 107-126.
32. Murray RM, O'Callaghan E, Castle DJ, Lewis SW (1992): A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull 18:319-332.